POINT Biopharma Global Inc (PNT) has gained 2.02% in a Week, Should You Hold?

Friday, October 13, 2023 11:32 AM | InvestorsObserver Analysts

Mentioned in this article

POINT Biopharma Global Inc (PNT) has gained 2.02% in a Week, Should You Hold?

The 62 rating InvestorsObserver gives to POINT Biopharma Global Inc (PNT) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 84 percent of stocks in the Biotechnology industry, PNT’s 62 overall rating means the stock scores better than 62 percent of all stocks.

PNT has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on PNT!

See Full PNT Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With POINT Biopharma Global Inc Stock Today?

POINT Biopharma Global Inc (PNT) stock has gained 2.22% while the S&P 500 is lower by -0.38% as of 11:32 AM on Friday, Oct 13. PNT is higher by $0.28 from the previous closing price of $12.36 on volume of 2,710,044 shares. Over the past year the S&P 500 has gained 18.07% while PNT is higher by 56.05%. PNT earned $0.81 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 15.64. Click Here to get the full Stock Report for POINT Biopharma Global Inc stock.